Author

F. Micoli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Alshayea· 1 shared A. E. Schager· 1 shared A. F. Cunningham· 1 shared A. J. Baumler· 1 shared A. Saul· 1 shared C. Giannelli· 1 shared C. Maclennan· 1 shared C. N. Cook· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Alshayea

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

S. E. Jossi, M. Arcuri, A. Alshayea, R. R. Persaud, E. Marcial-Juarez, E. Palmieri, R. Di Benedetto, M. Perez-Toledo, J. Pillaye, W. M. Channell, A. E. Schager, R. E. Lamerton, C. N. Cook, M. Goodall, T. Hanaeda, , A. F. Cunningham

This study compares the efficacy of Vi polysaccharide and conjugated Vi vaccines in protecting against Salmonella Typhi, finding that conjugated vaccines sustain immune responses better over time.

bioRxiv · Jan 3, 2023 · PreprintImmunology

Intralaboratory evaluation of luminescence based high-throughput Serum Bactericidal Assay (L-SBA) to determine bactericidal activity of human sera against Shigella

O. Rossi, E. Molesti, A. Saul, C. Giannelli, F. Micoli, F. Necchi

This paper develops and validates a high-throughput luminescence-based SBA (L-SBA) method to assess complement-mediated bactericidal activity of human sera against Shigella.

bioRxiv · Apr 3, 2020Immunology